Entity Details

Primary name MORC2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9Y6X9
EntryNameMORC2_HUMAN
FullNameATPase MORC2
TaxID9606
Evidenceevidence at protein level
Length1032
SequenceStatuscomplete
DateCreated2002-07-26
DateModified2021-06-02

Ontological Relatives

GenesMORC2

GO terms

Show/Hide Table
GOName
GO:0000287 magnesium ion binding
GO:0000792 heterochromatin
GO:0003682 chromatin binding
GO:0005524 ATP binding
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0006338 chromatin remodeling
GO:0006631 fatty acid metabolic process
GO:0006974 cellular response to DNA damage stimulus
GO:0008270 zinc ion binding
GO:0016363 nuclear matrix
GO:0016887 ATP hydrolysis activity
GO:0042803 protein homodimerization activity
GO:0045814 negative regulation of gene expression, epigenetic
GO:0045869 negative regulation of single stranded viral RNA replication via double stranded DNA intermediate
GO:0090309 positive regulation of DNA methylation-dependent heterochromatin assembly

Subcellular Location

Show/Hide Table
Subcellular Location
Chromosome
Cytoplasm
Nucleus
Nucleus matrix

Domains

Show/Hide Table
DomainNameCategoryType
IPR011124 Zinc finger, CW-typeDomainDomain
IPR036890 Histidine kinase/HSP90-like ATPase superfamilyFamilyHomologous superfamily
IPR041006 Morc, S5 domain 2-likeDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
616688 OMIMCharcot-Marie-Tooth disease 2Z (CMT2Z)An autosomal dominant, axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. The disease is caused by variants affecting the gene represented in this entry.